Jyotivardhan Jaipuria bullish on pharma space in near term

Jyotivardhan Jaipuria of Market Veteran told CNBC-TV18, "For me the pharma space is something which I have liked for quite a long time. My view is that at some point gradually I want to reduce my allocation to pharma though near term I am still bullish in them because one of the few sectors where you have seen earnings growth. However, if I have to look like two quarters- four quarters out I will probably be less bullish on pharma then I am now. So, it is something which on rises I want to cut my exposure a bit and get into more beaten down sectors."On Friday, Sun Pharmaceutical Industries ended at Rs 884.90, down Rs 3.95, or 0.44 percent on the BSE.